Search

Francesca Demichelis

from New York, NY
Age ~52
Get Report
Also known as:
Francesca Demichels
Phone and address:
455 Main St #7A, New York, NY 10044
Connected to:
Adam K Demicheli, 46Ashley L Demichele, 38Blase Demichele, 58Danny Demichele, 48Dominic L Demichele, 48Edward J Demichele, 54Eva Demicheli, 50Irene C Demichele, 81Jacqueline A Demichele, 59Lidiya C Demicheva, 62

Francesca Demichelis Phones & Addresses

  • 455 Main St #7A, New York, NY 10044
  • Los Angeles, CA
  • Cambridge, MA

Work

Company: University of trento 2011 Position: Assistant professor, centre for integrative biology

Education

School / High School: Imperial College London

Industries

Higher Education

Resumes

Resumes

Francesca Demichelis Photo 1

Assistant Professor, Centre For Integrative Biology At University Of Trento

View page
Position:
Assistant Professor, Centre for Integrative Biology at University of Trento, Assistant Professor, Instituite for Computational Biomedicine at Weill Cornell Medical College, NY
Location:
United States
Industry:
Higher Education
Work:
University of Trento since 2011
Assistant Professor, Centre for Integrative Biology
Weill Cornell Medical College, NY since 2008
Assistant Professor, Instituite for Computational Biomedicine
Weill Cornell Medical College - New York 2007 - 2011
Assistant Professor in Pathology and Laboratory Medicine
Harvard Medical School - Greater Boston Area 2005 - 2007
Post-doc
FBK 1998 - 2004
Researcher
Education:
Imperial College London
University of Trento

Publications

Us Patents

Biomarkers For Predicting Prostate Cancer Progression

View page
US Patent:
7666595, Feb 23, 2010
Filed:
Feb 24, 2006
Appl. No.:
11/361517
Inventors:
Mark A. Rubin - Cambridge MA, US
Francesca Demichelis - Cambridge MA, US
Assignee:
The Brigham and Women's Hospital, Inc. - Boston MA
International Classification:
C12Q 1/68
C07H 21/02
G01N 33/53
C07K 14/00
US Classification:
435 6, 435 71, 536 231, 536 243, 530350, 5303871
Abstract:
The present invention relates to the identification and use of gene expression profiles with clinical relevance to prostate cancer. In particular, the invention provides the identity of genes whose expression, at the transcriptional and protein levels, is correlated with prostate cancer progression. Methods and kits are described for using these gene expression profiles in the study and/or diagnosis of prostate cancer diseases, in the prediction of prostate cancer progression, and in the selection and/or monitoring of treatment regimens. The invention also relates to the screening of drugs that target these genes or their protein products, in particular for the development of therapeutics for modulating prostate cancer progression.

Recurrent Gene Fusions In Prostate Cancer

View page
US Patent:
7718369, May 18, 2010
Filed:
Sep 12, 2006
Appl. No.:
11/519397
Inventors:
Scott Tomlins - Ann Arbor MI, US
Daniel Rhodes - Ann Arbor MI, US
Arul Chinnaiyan - Plymouth MI, US
Rohit Mehra - Ann Arbor MI, US
Mark A. Rubin - Cambridge MA, US
Xiao-Wei Sun - New York NY, US
Sven Perner - Belmont MA, US
Charles Lee - Marlborough MA, US
Francesca Demichelis - New York NY, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
The Brigham and Women's Hospital, Inc. - Boston MA
International Classification:
C12Q 1/68
C12P 19/34
C07H 21/04
US Classification:
435 6, 435 912, 536 243
Abstract:
Recurrent gene fusions of androgen regulated genes and ETS family member genes in prostate cancer are described. Compositions and methods having utility in prostate cancer diagnosis, research, and therapy are also provided.

Biomarkers For Predicting Prostate Cancer Progression

View page
US Patent:
7803552, Sep 28, 2010
Filed:
Oct 27, 2009
Appl. No.:
12/607036
Inventors:
Mark A. Rubin - Cambridge MA, US
Francesca DeMichelis - Cambridge MA, US
Assignee:
The Brigham & Women's Hospital, Inc. - Boston MA
International Classification:
C12Q 1/68
G01N 33/53
C07H 21/02
C07K 14/00
US Classification:
435 6, 435 71, 536 231, 536 235, 536 243, 530350
Abstract:
The present invention relates to the identification and use of gene expression profiles with clinical relevance to prostate cancer. In particular, the invention provides the identity of genes whose expression, at the transcriptional and protein levels, is correlated with prostate cancer progression. Methods and kits are described for using these gene expression profiles in the study and/or diagnosis of prostate cancer diseases, in the prediction of prostate cancer progression, and in the selection and/or monitoring of treatment regimens. The invention also relates to the screening of drugs that target these genes or their protein products, in particular for the development of therapeutics for modulating prostate cancer progression.

Methods For Identifying And Using Snp Panels

View page
US Patent:
7981609, Jul 19, 2011
Filed:
Jun 8, 2007
Appl. No.:
11/811149
Inventors:
Mark A. Rubin - Cambridge MA, US
Francesca Demichelis - Cambridge MA, US
Levi A. Garraway - Newton MA, US
William R. Sellers - Brookline MA, US
Assignee:
The Brigham and Women's Hospital, Inc. - Boston MA
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
Described are methods for identifying single nucleotide polymorphism (SNPs) that are useful for analyzing genetic samples, and for using said SNPs to determine genetic identity of samples.

Recurrent Gene Fusions In Prostate Cancer

View page
US Patent:
8211645, Jul 3, 2012
Filed:
Dec 30, 2009
Appl. No.:
12/650164
Inventors:
Scott Tomlins - Ann Arbor MI, US
Daniel Rhodes - Ann Arbor MI, US
Arul Chinnaiyan - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Mark A. Rubin - New York NY, US
Xiao-Wei Sun - New York NY, US
Sven Perner - Ellwaugen, DE
Charles Lee - Marlborough MA, US
Francesca Demichelis - New York NY, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
The Brigham and Women's Hospital - Boston MA
International Classification:
C12Q 1/68
C12P 19/34
C07H 21/04
US Classification:
435 612, 435 912, 435810, 536 221, 536 243
Abstract:
Recurrent gene fusions of androgen regulated genes and ETS family member genes in prostate cancer are described. Compositions and methods having utility in prostate cancer diagnosis, research, and therapy are also provided.

Recurrent Gene Fusions In Prostate Cancer

View page
US Patent:
8580509, Nov 12, 2013
Filed:
May 30, 2012
Appl. No.:
13/483176
Inventors:
Scott Tomlins - Ann Arbor MI, US
Daniel Rhodes - Ann Arbor MI, US
Arul Chinnaiyan - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Mark A. Rubin - New York NY, US
Xiao-Wei Sun - New York NY, US
Sven Perner - Ellwaugen, DE
Charles Lee - Marlborough MA, US
Francesca Demichelis - New York NY, US
Assignee:
The Regents of The University of Michigan - Ann Arbor MI
The Brigham and Women's Hospital, Inc. - Boston MA
International Classification:
C12Q 1/68
C12P 19/34
C07H 21/02
C07H 21/04
US Classification:
435 612, 435 912, 435810, 536 221, 536 243
Abstract:
Recurrent gene fusions of androgen regulated genes and ETS family member genes in prostate cancer are described. Compositions and methods having utility in prostate cancer diagnosis, research, and therapy are also provided.

Recurrent Gene Fusions In Prostate Cancer

View page
US Patent:
20120296070, Nov 22, 2012
Filed:
May 30, 2012
Appl. No.:
13/483142
Inventors:
Scott Tomlins - Ann Arbor MI, US
Daniel Rhodes - Ann Arbor MI, US
Arul Chinnaiyan - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Mark A. Rubin - New York NY, US
Xiao-Wei Sun - New York NY, US
Sven Perner - Ellwaugen, DE
Charles Lee - Marlborough MA, US
Francesca Demichelis - New York NY, US
Assignee:
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. - Boston MA
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
C07K 16/18
US Classification:
5303897
Abstract:
Recurrent gene fusions of androgen regulated genes and ETS family member genes in prostate cancer are described. Compositions and methods having utility in prostate cancer diagnosis, research, and therapy are also provided.

Recurrent Gene Fusions In Prostate Cancer

View page
US Patent:
20130040858, Feb 14, 2013
Filed:
May 30, 2012
Appl. No.:
13/483157
Inventors:
Scott Tomlins - Ann Arbor MI, US
Daniel Rhodes - Ann Arbor MI, US
Arul Chinnaiyan - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Mark A. Rubin - New York NY, US
Xiao-Wei Sun - New York NY, US
Sven Perner - Ellwaugen, DE
Charles Lee - Marlborough MA, US
Francesca Demichelis - New York NY, US
Assignee:
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. - Boston MA
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
C40B 40/06
C07H 21/04
US Classification:
506 16, 536 2431, 536 234
Abstract:
Recurrent gene fusions of androgen regulated genes and ETS family member genes in prostate cancer are described. Compositions and methods having utility in prostate cancer diagnosis, research, and therapy are also provided.
Control profile
Francesca Demichelis from New York, NY, age ~52 Get Report